JPH0245501A - Chikusetsu ginseng polysaccharide and use thereof - Google Patents

Chikusetsu ginseng polysaccharide and use thereof

Info

Publication number
JPH0245501A
JPH0245501A JP63196454A JP19645488A JPH0245501A JP H0245501 A JPH0245501 A JP H0245501A JP 63196454 A JP63196454 A JP 63196454A JP 19645488 A JP19645488 A JP 19645488A JP H0245501 A JPH0245501 A JP H0245501A
Authority
JP
Japan
Prior art keywords
water
polysaccharide
bamboo
pjn
polysaccharide component
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP63196454A
Other languages
Japanese (ja)
Inventor
Osamu Tanaka
治 田中
Ryoji Kasai
笠井 良次
Kazuhiro Otani
和弘 大谷
Hisami Hirose
広瀬 久美
Shunzo Hatono
鳩野 俊三
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wakunaga Pharmaceutical Co Ltd
Original Assignee
Wakunaga Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wakunaga Pharmaceutical Co Ltd filed Critical Wakunaga Pharmaceutical Co Ltd
Priority to JP63196454A priority Critical patent/JPH0245501A/en
Publication of JPH0245501A publication Critical patent/JPH0245501A/en
Pending legal-status Critical Current

Links

Landscapes

  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

NEW MATERIAL:A compound having a mol.wt. of 20000-180000 and containing saccharides selected from arabinose, xylose, rhamnose, fucose, glucose, galactose and galacturonic acid as constituting components thereof. USE:A biophylaxis ability-accelerating agent. Low toxicity. PREPARATION:CHIKUSETSU ginseng (Panax Schinseng Nees var. japonicum Makino) belonging to the genus Panax in the family Arallaceae is ground and subsequently extracted with a water-soluble organic solvent such as methanol. The extraction residue is extracted with water and subsequently mixed with a water-soluble organic solvent such as ethanol to produce precipitates. The precipitates are finally subjected to a chromatography using an ion exchange resin or gel filtration agent.

Description

【発明の詳細な説明】 〔発明の背景〕 技術分野 本発明は、竹節ニンジンから単離された新規多糖成分お
よびこれを有効成分とする生体防御能亢進剤に関する。
DETAILED DESCRIPTION OF THE INVENTION [Background of the Invention] Technical Field The present invention relates to a novel polysaccharide component isolated from ginseng and a biodefense enhancer containing the polysaccharide component as an active ingredient.

従来の技術 竹節ニンジンは、中国四用、雲南省等に生息する多年生
草本で、中国では正咳・1に血あるいは条面の治療薬と
して用いられている。
BACKGROUND OF THE INVENTION Bamboo knot ginseng is a perennial herb that inhabits China's Siyong and Yunnan provinces, and is used in China as a treatment for cough 1, blood, and rays.

また、竹節ニンジン中の成分については、チクセツサポ
ニンL  Ia、Ib、IIIおよび■等のサポニン類
が単離、構造決定されている。しかしながら、多糖成分
についての報告はほどんど見当たらず、まだまだ研究の
余地を残しているのが現状である。
Furthermore, regarding the components in bamboo knot ginseng, saponins such as Chiksetsusaponin L Ia, Ib, III and ■ have been isolated and their structures have been determined. However, there are almost no reports on polysaccharide components, and there is still room for research.

ところで、人間は一般に老齢になると諸疾患に対する抵
抗能が低下して種々の病気に罹患しやすくなる。原因と
しては、体内諸器官や種々の代謝作用が衰えるとともに
異物や老廃物の処理作用のある食細胞の機能が低下し、
生体防御能が衰えることが考えられる。
By the way, as humans grow older, their ability to resist various diseases generally decreases, making them more susceptible to various diseases. The cause is a decline in various internal organs and metabolic processes, as well as a decline in the function of phagocytes, which process foreign substances and waste.
It is thought that the body's defense ability declines.

本発明者は、竹節ニンジンの成分について研究を重ねた
結果、竹節ニンジン中に新規な多糖成分を発見したこと
、およびこの多糖成分に生体防御能があることを発見し
て本発明を完成するに至った。
As a result of repeated research on the components of Bamboo-bushi carrots, the present inventor discovered a new polysaccharide component in Bamboo-bushi carrots, and discovered that this polysaccharide component has biological defense ability, and was able to complete the present invention. It's arrived.

〔発明の概要〕[Summary of the invention]

要旨 本発明は新規な多糖成分およびこれを有効成分とする生
体防御能亢進剤の提供を目的とし、竹節ニンジン中の多
糖成分がこの作用を有するという・当業者にとっても思
わぬ発見に基づくものである。
Summary The present invention aims to provide a novel polysaccharide component and a biodefense enhancer containing the polysaccharide component as an active ingredient, and is based on the unexpected discovery, even for those skilled in the art, that the polysaccharide component in bamboo-fried carrots has this effect. be.

したがって、本発明による竹節ニンジン由来の多糖は、
分子量が約20,000〜 180.000で、且つ構成糖が゛7ラビノース、キシ
ロース、ラムノース、フコース、グルコース、ガラクト
ースおよびガラクツロン酸から選ばれたものであること
、を特徴とするものである。
Therefore, the polysaccharide derived from bamboo knot carrot according to the present invention is
It is characterized by having a molecular weight of about 20,000 to 180,000, and a constituent sugar selected from ``7-rabinose, xylose, rhamnose, fucose, glucose, galactose, and galacturonic acid.''

また、本発明による生体防御能亢進剤は、分子量が約2
0,000〜180.000で、且つ構成糖がアラビノ
ース、キシロース、ラムノース、フコース、グルコース
、ガラクトースおよびガラクツロン酸から選ばれたもの
である竹節ニンジン由来の多糖を有効成分とすること、
を特徴とするものである。
Furthermore, the biological defense ability enhancer according to the present invention has a molecular weight of about 2
0,000 to 180,000 and whose constituent sugars are selected from arabinose, xylose, rhamnose, fucose, glucose, galactose and galacturonic acid, as an active ingredient;
It is characterized by:

効果 本発明による竹節ニンジンの新規な多糖成分は優れた生
体防御能を有しており、この多糖成分を有効成分とする
本発明による生体防御能亢進剤は、生体に侵入した細菌
やウィルス等の異物に対するマクロファージの貧食作用
等の生体防御反応を活性化して、異物を生体から排除す
る機能を増加させ、これによって諸疾患に対する抵抗能
を高めることができるものであり、しかもその毒性も低
いものである。従って、本発明による多糖成分およびこ
れを釘効成分とする生体防御能亢進剤の提供は、生体の
抵抗性に係る諸疾患対策にa意義な貢献をなすものであ
る。
Effect The novel polysaccharide component of the bamboo-fried carrot according to the present invention has an excellent biological defense ability, and the biological defense ability enhancer according to the present invention containing this polysaccharide component as an active ingredient is effective against bacteria, viruses, etc. that invade the body. A substance that activates biological defense reactions such as phagocytosis of macrophages against foreign substances, increases the ability to eliminate foreign substances from the body, and thereby increases resistance to various diseases, and has low toxicity. It is. Therefore, the provision of a polysaccharide component and a biodefense enhancer containing the polysaccharide component as a nail-acting component according to the present invention will make a significant contribution to measures against various diseases related to bioresistance.

〔発明の詳細な説明〕[Detailed description of the invention]

竹節ニンジン 本発明でいう竹節ニンジンとは、ウコギ科(Arall
aceae) 、パナックス属(Panax )に属す
るPanax Sehinseng Nees var
、 japonlcum Makin。
Bamboo-bush carrots Bamboo-bushi carrots as used in the present invention refer to Arallaceae (Arallaceae).
aceae), Panax Sehinseng Nees var belonging to the genus Panax
, japonlcum Makin.

(−P、 japonlcus C,A、 Mey、)
をいう。
(-P, japonlucus C, A, Mey,)
means.

多糖成分を取得すべき部分はとりわけ根部が好ましく、
取得効率を考えれば、乾燥したものを用いるのが好都合
である。また、竹節ニンジンの適当な部位を常法により
組織培養に付し、その培養物を用いることもできる。
The root is particularly preferred as the part from which polysaccharide components should be obtained;
Considering the acquisition efficiency, it is convenient to use dry ones. It is also possible to subject an appropriate part of a bamboo joint carrot to tissue culture by a conventional method and use the cultured product.

多糖成分およびその取得方法 本発明でいう竹節ニンジン由来の多糖成分は、分子量的
20,000〜180.000で、かつ構成糖がアラビ
ノース(Ara)、キシロース(Xyl)、ラムノーム
(Rha)、フコース(Fuc)、グルコース(G l
 c) 、ガラクトース(Gal)およびガラクツロン
酸(GalA)から選ばれたものである。従って、この
多糖成分は実質的に上記の糖のみからなっており、その
構成糖の種類は上記糖のいずれか一種のみでもよいし、
複数種の組み合わせであってもよい。
Polysaccharide component and method for obtaining the same The polysaccharide component derived from bamboo knot carrots as used in the present invention has a molecular weight of 20,000 to 180,000, and the constituent sugars are arabinose (Ara), xylose (Xyl), rhamnome (Rha), and fucose ( Fuc), glucose (G l
c) selected from galactose (Gal) and galacturonic acid (GalA). Therefore, this polysaccharide component essentially consists of only the above-mentioned sugars, and the constituent sugars may be only one of the above-mentioned sugars,
It may be a combination of multiple types.

この様な多糖成分の具体例について示せば、以下の通り
である。
Specific examples of such polysaccharide components are as follows.

本発明でいう多糖成分を取得するためには、竹節ニンジ
ンから該成分を単離することのできる任意の方法を用い
ればよい。例えば、竹節ニンジンを好ましくは破砕後、
水溶性有機溶媒に浸漬して抽出を行ない、その残渣を水
で抽出し、これに水溶性有機溶媒を加えて沈殿物を得る
。そして沈殿物をイオン交換樹脂もしくはゲルン濾過剤
を用いたクロマトグラフィーに付し、目的物を得ること
かできる。原料ニンジンは脱脂操作に付してもよく、ま
た上記沈殿物を透析に付しても目的物を得ることができ
よう。
In order to obtain the polysaccharide component as referred to in the present invention, any method capable of isolating the component from bamboobrush carrots may be used. For example, after crushing bamboo-fried carrots,
Extraction is performed by immersion in a water-soluble organic solvent, the residue is extracted with water, and a water-soluble organic solvent is added to obtain a precipitate. The desired product can then be obtained by subjecting the precipitate to chromatography using an ion exchange resin or a gel filter agent. The raw material carrot may be subjected to a defatting operation, and the desired product may also be obtained by subjecting the precipitate to dialysis.

この多糖成分の単離に関する詳細は、後記実施例を参照
されたい。
For details regarding the isolation of this polysaccharide component, please refer to the Examples below.

生体防御能亢進剤 本発明の生体防御能亢進剤は竹節ニンジンの多糖成分そ
れ自体または適宜製剤用の賦形剤、結合剤、希釈剤と混
合して成るものであり、粉末、顆粒、錠剤、カプセル剤
、シロップ剤、注射剤などの形態で経口的または非経口
的に投与することができる。また、必要に応じて他の薬
剤を調合させてもよい。投与量は、年齢、体重、症状に
より適宜増減するが、経口的には通常成人、1日、多糖
成分として0.1〜b しい具体例は、竹節ニンジンの多糖成分と製剤上の補助
成分とからなるものである。また、本発明の他の好まし
い具体例は、上記1日当たりの投与量を1回ないし数回
に分けて服用させるための単位投与形態のものである。
Biodefense Enhancing Agent The biodefense enhancing agent of the present invention is composed of the polysaccharide component of Bamboo Bush Carrot itself or mixed with appropriate excipients, binders, and diluents for formulation, and can be used in powders, granules, tablets, It can be administered orally or parenterally in the form of capsules, syrups, injections, and the like. Further, other drugs may be mixed as necessary. The dosage may vary depending on age, body weight, and symptoms, but it is usually 0.1 to 0.1 b per day for adults per day as a polysaccharide component. It consists of Another preferred embodiment of the present invention is a unit dosage form in which the above-mentioned daily dose is divided into one or several doses.

なお、本発明における多糖成分の毒性は、例えば、後記
実験例におけるPI3−2、PI3−3、PJN−1及
びP J N−3の場合、ICR系雄性マウス(5匹)
に対する4mg/kgの腹腔内投与で一般症状に異常が
全く認められなかったこと、およびこれらの物質と構造
類似であるレンチナン(木村郁部はか、最新医学、36
.1084(1981))およびPS−K (クレスチ
ン(三共))等が周知の通りの低毒性であることにより
、一般に低いものと考えることができる。
In addition, the toxicity of the polysaccharide component in the present invention is, for example, in the case of PI3-2, PI3-3, PJN-1, and PJN-3 in the experimental examples described later, in the case of ICR male mice (5 mice).
No abnormalities were observed in general symptoms after intraperitoneal administration of 4 mg/kg to
.. 1084 (1981)) and PS-K (Krestin (Sankyo)), etc., are generally considered to have low toxicity, as they are well known to have low toxicity.

生体防御能亢進作用 生体に異物(細菌、ウィルス、等)が侵入すると、これ
に対してマクロファージの貧食作用等の生体防御反応が
現イ)れ、外敵を排除する巧妙な機構が生じてくる。し
かし、免疫低下または防御因子低下時には、攻撃因子(
異物)優勢となって、日和見感染等の各種疾患に罹りや
すくなる。
Enhancement of biological defense ability When foreign substances (bacteria, viruses, etc.) invade the living body, biological defense reactions such as phagocytosis of macrophages occur in response, and an ingenious mechanism is created to eliminate the foreign enemy. . However, when immunity or protective factors decrease, attacking factors (
foreign substances) become predominant, making you more susceptible to various diseases such as opportunistic infections.

本発明でいう生体防御能亢進作用は、上記に示した様な
生体防御反応を活性化して、異物を生体から排除する作
用をいい、二次的な抗ウィルス、抗腫瘍、抗寄生虫、抗
細菌作用およびその他の外来性抗原の排除に関するもの
である。
In the present invention, the action of enhancing biological defense function refers to the action of activating the biological defense reactions shown above to eliminate foreign substances from the living body, and has secondary antiviral, antitumor, antiparasitic, and antiviral effects. It concerns the elimination of bacterial action and other foreign antigens.

実験例 1)多糖成分の取得 第1図の工程図に従い、竹節ニンジンをメタノール(M
eOH)で抽出した残渣を水に溶解しエタノール(E 
t OH)を加えて得た沈殿(EtOHppt  収率
6.38%)をDEAE−TOYOPEARL  65
0Mを充填したカラム(40mmX 700mm)に付
し、P J N。
Experimental example 1) Acquisition of polysaccharide components According to the process diagram in Figure 1, bamboo section carrots were mixed with methanol (M
The residue extracted with eOH) was dissolved in water and ethanol (EOH) was extracted.
DEAE-TOYOPEARL 65
P J N was applied to a column (40 mm x 700 mm) packed with 0M.

PJI、PI3、PI3、PI4のフラクションヲ得、
PJNおよびPI3のフラクションを再度DEAE−T
OYOPEARL  650Mに付してPJN−1(収
率0,28%) 、PJN−3(収率0,28%) 、
PJ2−2 (収率0、088%> 、PJ2−3 (
0,057%)のフラクションを得た(ただし、各収率
は初めの竹節ニンジン(乾燥)に対する重量%である)
Obtain fractions of PJI, PI3, PI3, PI4,
The PJN and PI3 fractions were DEAE-T again.
PJN-1 (yield 0.28%), PJN-3 (yield 0.28%),
PJ2-2 (yield 0, 088%>, PJ2-3 (
(0,057%) was obtained (however, each yield is the weight % based on the initial bamboo-fried carrot (dry)).
.

これらのフラクションは、糖含量をフェノール硫酸法に
より、ウロン酸含量をカルバゾール硫酸法により、また
タンパク含量をローリ−(Lovry )法によって各
々7Illl定した。
The sugar content of these fractions was determined by the phenol-sulfuric acid method, the uronic acid content by the carbazole-sulfuric acid method, and the protein content by the Lovry method.

また、構成糖の決定にあたっては、1Nの硫酸で氷解後
、常法により還元、アセチル化後、ガスクロマトグラフ
ィー(G L C)により分析した。
Further, in determining the constituent sugars, the ice was thawed with 1N sulfuric acid, reduced and acetylated by a conventional method, and then analyzed by gas chromatography (GLC).

また、糖の結合様式の決定にあたっては、メチル化、酸
加水分解後、ガスクロマトグラフ質量分析(G C−M
S)により分析した。
In addition, in determining the binding mode of sugars, after methylation and acid hydrolysis, gas chromatography mass spectrometry (G C-M
Analyzed by S).

これらの結果は以下に示す通りである。These results are shown below.

(i)PJN−1 分子量:23,000.Cα)D+49.5゜(c−0
,5、水) 元素分析:C39,29%、H6,36%N0.03% タンパク分析:未検出(ローリ−法) 総轄ffi:95.5%(標準物質:Gal、フェノー
ル硫酸法) ウロン酸分析:未検出(カルバゾール硫酸法)酸加水分
解:D−Gal メチル化分析:Galの4位Cに結合 ’H−NMR(i n  D20)δ:4.45(アノ
7−H,d、J−6,7Hz) 13C−NMR(i n  D20)δ:105.1(
C−1) 、72.8 (C−2) 、75.3(C−
3) 、78.3 (C−4) 、74.2(C〜5)
 、61.6 (C−6)。
(i) PJN-1 Molecular weight: 23,000. Cα)D+49.5°(c-0
, 5, water) Elemental analysis: C39, 29%, H6, 36% N0.03% Protein analysis: Not detected (Lowry method) General FFI: 95.5% (standard material: Gal, phenol sulfuric acid method) Uronic acid Analysis: Undetected (carbazole sulfuric acid method) Acid hydrolysis: D-Gal Methylation analysis: Bonded to the 4-C position of Gal'H-NMR (in D20) δ: 4.45 (Ano 7-H, d, J -6,7Hz) 13C-NMR (in D20) δ: 105.1 (
C-1), 72.8 (C-2), 75.3 (C-
3), 78.3 (C-4), 74.2 (C-5)
, 61.6 (C-6).

PJN−1の構造 β−1,4−がラフタン。Structure of PJN-1 β-1,4- is raftan.

n:正の整数 N)PJN−3 分子量:40,000、〔・’t’  +56.O。n: positive integer N) PJN-3 Molecular weight: 40,000, [・'t' +56. O.

(c−0,5、水) 元素分析:C37,47%、H6,22%NO,04% タンパク分析:未検出(ローリ−法) 総轄量:94.0%(フェノール硫酸法)(標章物質:
Gal、AraSGlc。
(c-0,5, water) Elemental analysis: C37,47%, H6,22% NO,04% Protein analysis: Not detected (Lowry method) Total amount: 94.0% (phenol sulfuric acid method) (Mark material:
Gal, AraSGlc.

Ga1A)(26:2.4:0.5:1)(モル比) ウロン酸分析、3.5%(標■物質:Ga1A、カルバ
ゾール硫酸法) カルボキシル基の還元(テーラ−・コンラッドの還元) PJN−3〜PJN−3R(還元物) 酸加水分解= (IN H2SO4,100℃、4h) L−Ara  D−Gal  D−GlcPJN−31
,010,90,2 PJN−3の構造 R=側鎖二 −Ga L−Glc、−Ara (f)−
(5”−1)−Ara (f)f:フラノース型(その
他はすべてピラノース型)X:2または6または2.3
または3.6(2+3:2:5)(モル比)。なおXが
2つの部位の時Rは2分子となる。
Ga1A) (26:2.4:0.5:1) (molar ratio) Uronic acid analysis, 3.5% (standard substance: Ga1A, carbazole sulfuric acid method) Reduction of carboxyl group (Taylor-Conrad reduction) PJN-3 to PJN-3R (reduced product) Acid hydrolysis = (IN H2SO4, 100°C, 4h) L-Ara D-Gal D-GlcPJN-31
,010,90,2 PJN-3 structure R = side chain 2 -Ga L-Glc, -Ara (f)-
(5”-1)-Ara (f) f: Furanose type (all others are pyranose type) X: 2 or 6 or 2.3
or 3.6 (2+3:2:5) (molar ratio). Note that when X has two sites, R has two molecules.

nl :正の整数 (iii)  P J 2−2 分子量:170.000、 〔α)、+57.C(c−
0,3、水) 元素分析:C36,96%、H6,12$N0.06% タンパク分析:未検出(ローリ−法) 総轄量:90.2%(フェノール硫酸法)(標準物質:
 A r a、Rha、Ga l。
nl: positive integer (iii) P J 2-2 Molecular weight: 170.000, [α), +57. C(c-
0.3, water) Elemental analysis: C36,96%, H6,12$N0.06% Protein analysis: Not detected (Lowry method) Total amount: 90.2% (phenol sulfuric acid method) (Standard material:
Ara, Rha, Gal.

Ga1A)(3:1.5:4.5:1)(−jル比) ウロン酸分析:10.0% (標準物質:Ga1A、カルバゾール硫酸法)カルボキ
シル基の還元(テーラ−・コンラッの還元) PI3−2−PI3−2R(還元物) 酸加水分解: (IN H2SO4,100℃、4h) L−Ara D−Xyl  L−Rha L−Fue 
D−Glc D−G;PI3−2   2.5  1.
0 1.4  0.5  1.0  4.・PI3−2
R2,51,01,40,51,05゜(いずれもモル
比 (Iv)P J 2−3 分子】・40,000、〔α’t7 +65.0゜(c
−0,3、水) 元素分析:C38,12%、H6,32%NO,08% タンパク分析;未検出(ローリ−法) 総轄ffi:87.0%(フェノール硫酸法)(標準物
質:Ara、Rha、Ga 1.Ga IA)(2,1
:1.6:2.1:1.O)(モル比)ウロン酸分析:
14.7% (標僧物質:Ga1A、カルバゾール硫酸法)カルボキ
シル基の還元(テーラ−・コンラッドの還元) P J 2−3−P J 2−3R(還元物)酸加水分
解= (1N H2SO4,100℃、4h) L−Ara D−Xyl L−Rha L−Fuc D
−Glc D−GalPJ2−3  3.2 1.0 
2.Ili  O,50,63,7PJ2−31?  
3.2 10 2.G  O,50,65,7(いずれ
もモル比) 3PJ2−3の構造 〔■〕 R−側鎖:−Rha、−Fuc、−Xy 1部分式〔■
〕、〔■〕、■旧、門〕 =4者の結合は順不同n6、
n7、n8、n9 、正の整数 2)多糖成分のカーボンクリアランス(Carbonc
learance )能活性効果 (1)実験動物 ICR系雄性マウスを一定期間飼育後、健康と思われる
5週齢のものを1群10匹として本実験に使用した。
Ga1A) (3:1.5:4.5:1) (-j ratio) Uronic acid analysis: 10.0% (Standard material: Ga1A, carbazole sulfuric acid method) Reduction of carboxyl group (Taylor-Conrad reduction) ) PI3-2-PI3-2R (reduced product) Acid hydrolysis: (IN H2SO4, 100°C, 4h) L-Ara D-Xyl L-Rha L-Fue
D-Glc DG; PI3-2 2.5 1.
0 1.4 0.5 1.0 4.・PI3-2
R2,51,01,40,51,05゜(all molar ratio (Iv) P J 2-3 molecules]・40,000, [α't7 +65.0゜(c
-0.3, water) Elemental analysis: C38, 12%, H6, 32% NO, 08% Protein analysis: Not detected (Lowry method) General FFI: 87.0% (phenol sulfuric acid method) (Standard material: Ara , Rha, Ga 1.Ga IA) (2,1
:1.6:2.1:1. O) (molar ratio) uronic acid analysis:
14.7% (Standard substance: Ga1A, carbazole sulfuric acid method) Reduction of carboxyl group (Taylor-Conrad reduction) P J 2-3-P J 2-3R (reduced product) Acid hydrolysis = (1N H2SO4, 100°C, 4h) L-Ara D-Xyl L-Rha L-Fuc D
-Glc D-GalPJ2-3 3.2 1.0
2. Ili O,50,63,7PJ2-31?
3.2 10 2. G O, 50, 65, 7 (all molar ratios) Structure of 3PJ2-3 [■] R-side chain: -Rha, -Fuc, -Xy 1 partial formula [■
], [■], ■old, gate] = 4 combinations are in any order n6,
n7, n8, n9, positive integer 2) Carbon clearance of polysaccharide component
(1) Experimental Animals After breeding ICR male mice for a certain period of time, 5-week-old mice that appeared to be healthy were used in this experiment as a group of 10 mice.

(2)実験方法 ハルバーン(Ilalpern )らのカーボン・クリ
アランス法(Ilalpern、 B、11.、 et
al、、 J、 ReLieulo−endotl+e
1. Soc、 l、 77 (1964) )に従い
、上記のマウスに下記に示す濃度の被検液(多糖成分と
してはPI3−2及びPI3−3を用いた)を腹腔的投
与し、24時間後にカーボン懸濁液(ペリカン・インク
(ペリカン社製)を生理食塩水で4倍希釈したもの)を
5 ml / kgの割合で、尾静脈投与した。2分お
よび10分後にマウスの眼窩からマイクロピペットを用
いて20μlの血液を採取した。
(2) Experimental method Carbon clearance method of Ilalpern et al. (Ilalpern, B, 11., et al.
al,, J, ReLieulo-endotl+e
1. Soc, I, 77 (1964)), a test solution (PI3-2 and PI3-3 were used as polysaccharide components) was administered intraperitoneally to the above mice at the concentrations shown below, and 24 hours later, carbon suspension was applied. A suspension (Pelican Inc. (manufactured by Pelican) diluted 4 times with physiological saline) was administered into the tail vein at a rate of 5 ml/kg. After 2 and 10 minutes, 20 μl of blood was collected from the mouse's orbit using a micropipette.

得られた血液に0.1%Na2CO3溶液2mlを加え
て溶血させた後、分光光度計(品性製作所)を用いて6
75nmにおける吸光度(OD 675 )をAl11
定して、カーボン懸濁液の血中消失速度を求めた(対照
は1)。
After adding 2 ml of 0.1% Na2CO3 solution to the obtained blood to cause hemolysis, 6 ml of 0.1% Na2CO3 solution was added using a spectrophotometer (Kinsei Seisakusho).
Absorbance at 75 nm (OD 675 ) of Al11
The rate of disappearance of the carbon suspension in the blood was determined using the following parameters (control: 1).

同様にして他の被検液(多糖成分としてはPJN−1及
びPJN−3)についても試験を行った(対照は2)。
Similarly, other test solutions (polysaccharide components: PJN-1 and PJN-3) were also tested (control 2).

(被検液の投与量) (イ)生理食塩水(対照1及び2 )  5 ml /
 kg(ロ)多糖成分 4II1g/kg  −=0.
 8mg/ml (5ml / kg ) なお、結果の統計的処理はステニープント(Stude
nt’s )  を検定ニテ行ナツタ。
(Dosage of test solution) (a) Physiological saline (controls 1 and 2) 5 ml/
kg (b) Polysaccharide component 4II1g/kg -=0.
8mg/ml (5ml/kg) The statistical processing of the results was performed by Studepund.
nt's) to test Nite row Natsuta.

竹節ニンジンより得られた多糖、PJN−1、PJN−
3、P J 2−2、PI3−3をマウスに投与した際
の結果を第2図に示す。これらのニンジン多糖投与群は
何れも非投与の対象群に比べて早い消失速度を与え、異
物処理能力が、著しく亢進していることが示された。
Polysaccharides obtained from bamboobrush carrots, PJN-1, PJN-
FIG. 2 shows the results when 3, P J 2-2, and PI3-3 were administered to mice. All of these carrot polysaccharide administration groups showed a faster elimination rate than the non-administration control group, indicating that the ability to dispose of foreign substances was significantly enhanced.

【図面の簡単な説明】[Brief explanation of the drawing]

第1図は竹節ニンジンから目的多糖を分離する工程を示
す図である。 第2図は竹節ニンジン由来多糖のカーボンクリアランス
能増強作用を示すグラフである。
FIG. 1 is a diagram showing the process of separating the target polysaccharide from bamboobrush carrots. FIG. 2 is a graph showing the effect of enhancing carbon clearance ability of the polysaccharide derived from bamboo knot carrots.

Claims (1)

【特許請求の範囲】 1、分子量が約20,000〜180,000で、且つ
構成糖がアラビノース、キシロース、ラムノース、フコ
ース、グルコース、ガラクトースおよびガラクツロン酸
から選ばれたものである、竹節ニンジン由来の多糖。 2、分子量が約20,000〜180,000で、且つ
構成糖がアラビノース、キシロース、ラムノース、フコ
ース、グルコース、ガラクトースおよびガラクツロン酸
から選ばれたものである、竹節ニンジン由来の多糖を有
効成分とする生体防御能亢進剤。
[Scope of Claims] 1. A bamboo-bush carrot-derived product having a molecular weight of about 20,000 to 180,000 and having a constituent sugar selected from arabinose, xylose, rhamnose, fucose, glucose, galactose and galacturonic acid. Polysaccharide. 2. The active ingredient is a polysaccharide derived from ginseng, which has a molecular weight of about 20,000 to 180,000 and whose constituent sugars are selected from arabinose, xylose, rhamnose, fucose, glucose, galactose, and galacturonic acid. Biodefense enhancer.
JP63196454A 1988-08-06 1988-08-06 Chikusetsu ginseng polysaccharide and use thereof Pending JPH0245501A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP63196454A JPH0245501A (en) 1988-08-06 1988-08-06 Chikusetsu ginseng polysaccharide and use thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP63196454A JPH0245501A (en) 1988-08-06 1988-08-06 Chikusetsu ginseng polysaccharide and use thereof

Publications (1)

Publication Number Publication Date
JPH0245501A true JPH0245501A (en) 1990-02-15

Family

ID=16358080

Family Applications (1)

Application Number Title Priority Date Filing Date
JP63196454A Pending JPH0245501A (en) 1988-08-06 1988-08-06 Chikusetsu ginseng polysaccharide and use thereof

Country Status (1)

Country Link
JP (1) JPH0245501A (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005531576A (en) * 2002-05-28 2005-10-20 エムディー バイオアルファ カンパニー リミテッド Fractions with anticancer and antimetastatic activity from carrot leaves and stems
EP1124982B1 (en) * 1999-08-27 2007-07-04 Korea Atomic Energy Research Institute THE HEMATOPOIETIC, MYELOPROTECTING, ANTITUMOR IMMUNE CELLS GENERATING AND RADIOSENSITIZING POLYSACCHARIDE ISOLATED FROM i PANAX GINSENG /i
JP2009256387A (en) * 1997-12-12 2009-11-05 Fx Life Sciences Ag Process of making north american ginseng fraction, product containing the same and use as immunomodulator
US8039027B1 (en) * 1999-02-25 2011-10-18 Fx Life Sciences Ag Treatment of autoimmune diseases with American ginseng extract
US9050313B2 (en) 2008-02-29 2015-06-09 Valeant Canada Lp Activation of innate and adaptive immune responses by a ginseng extract
JP2018024737A (en) * 2016-08-09 2018-02-15 株式会社ゲノム創薬研究所 Polysaccharide with innate immunity activating action, and innate immunity activating agent or food/drink containing said polysaccharide

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009256387A (en) * 1997-12-12 2009-11-05 Fx Life Sciences Ag Process of making north american ginseng fraction, product containing the same and use as immunomodulator
US8039027B1 (en) * 1999-02-25 2011-10-18 Fx Life Sciences Ag Treatment of autoimmune diseases with American ginseng extract
EP1124982B1 (en) * 1999-08-27 2007-07-04 Korea Atomic Energy Research Institute THE HEMATOPOIETIC, MYELOPROTECTING, ANTITUMOR IMMUNE CELLS GENERATING AND RADIOSENSITIZING POLYSACCHARIDE ISOLATED FROM i PANAX GINSENG /i
JP2005531576A (en) * 2002-05-28 2005-10-20 エムディー バイオアルファ カンパニー リミテッド Fractions with anticancer and antimetastatic activity from carrot leaves and stems
US9050313B2 (en) 2008-02-29 2015-06-09 Valeant Canada Lp Activation of innate and adaptive immune responses by a ginseng extract
JP2018024737A (en) * 2016-08-09 2018-02-15 株式会社ゲノム創薬研究所 Polysaccharide with innate immunity activating action, and innate immunity activating agent or food/drink containing said polysaccharide
WO2018030542A1 (en) * 2016-08-09 2018-02-15 イマジン・グローバル・ケア株式会社 Polysaccharide having natural immunostimulatory action and natural immunostimulant or food or drink comprising same
US11213058B2 (en) 2016-08-09 2022-01-04 Imagine Global Care Corporation Polysaccharide having innate immunity stimulating activity

Similar Documents

Publication Publication Date Title
Zhang et al. Composition, isolation, purification and biological activities of Sargassum fusiforme polysaccharides: A review
Chihara et al. Fractionation and purification of the polysaccharides with marked antitumor activity, especially lentinan, from Lentinus edodes (Berk.) Sing.(an edible mushroom)
US5268467A (en) Immunomodulatory polysaccharide fractions from Astragalus plants
CN110437288B (en) Sea cucumber fucoidin and preparation method and application thereof
KR100361187B1 (en) The hematopoietic, myeloid protecting, antitumor immune cells generating and radiosensitizing polysaccharide isolated from Panax ginseng
CN109400742B (en) Dendrobium devonianum refined polysaccharide and preparation method and application thereof
US4289688A (en) Protein-bound polysaccharides
JPS58201719A (en) Biologically active polysaccharide concentrate and manufacture of composition containing same
CZ70896A3 (en) Pharmaceutical preparation and the use of galacturonides for preparing thereof
JPH0784388B2 (en) Calcium and magnesium complex compound of phytohemagglutinin-polyheteroglycan
CN107216405A (en) The preparation technology and its structure sequence of a kind of highland barley beta glucan
CN115028750A (en) Ascophyllum nodosum fucoidin and preparation method and application thereof
Shanmugam et al. Screening of Codiacean algae (Chlorophyta) of the Indian coasts for blood anticoagulant activity
JPH0245501A (en) Chikusetsu ginseng polysaccharide and use thereof
US20050287230A1 (en) Method of producing ginsenoside 20 (R)-Rh2 and composition of matter thereof
Wang et al. Anti-hyperglycemic effect of the polysaccharide fraction isolated from Mactra veneriformis
WO1990009181A1 (en) Anti-hiv drug
US4614733A (en) Polysaccharides pharmaceutical compositions and the use thereof
JPH0245499A (en) Glycoprotein of panax ginseng and use thereof
Ingólfsdóttir Bioactive compounds from Iceland moss
CN1169839C (en) Wolfberry polysaccharide and its prepn. and application
JP2602295B2 (en) Polysaccharide, method for isolating the same, and pharmaceutical composition containing the polysaccharide
DE3881198T2 (en) ANTIVIRAL ACTIVE SUBSTANCE.
Qian et al. Physical-chemical properties of heteropolysaccharides from different processed forms of Rehmanniae Radix
US6015796A (en) Method for treating AIDS